FG Annuities Life Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| F&G Annuities & Life, Inc. (Registrant) | |||
| Date: | February 29, 2024 | By: | /s/ Wendy J.B. Young |
|---|---|---|---|
| Chief Financial Officer | |||
| (on behalf of the Registrant and as Principal Financial Officer) | |||
POWERS OF ATTORNEY
KNOW ALL BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Christopher O. Blunt and Wendy J.B. Young, and each of them, acting individually, as his true and lawful attorney-in-fact and agent, each with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated
| Signature | Title | Date |
|---|---|---|
| /s/ Christopher O. Blunt | Director, President and Chief Executive Officer | February 29, 2024 |
| Christopher O. Blunt | (Principal Executive Officer) | |
| /s/ Wendy J.B. Young | Chief Financial Officer | February 29, 2024 |
| Wendy JB Young | (Principal Financial and Accounting Officer) | |
| /s/ William P. Foley, II | Director and Executive Chairman of the Board | February 29, 2024 |
| William P. Foley, II | ||
| /s/ Douglas K. Ammerman | Director | February 29, 2024 |
| Douglas K. Ammerman | ||
| /s/ Celina J. Wang Doka | Director | February 29, 2024 |
| Celina Wang Doka | ||
| /s/ Douglas Martinez | Director | February 29, 2024 |
| Douglas Martinez | ||
| /s/ Michael J. Nolan | Director | February 29, 2024 |
| Michael J. Nolan | ||
| /s/ Raymond R. Quirk | Director | February 29, 2024 |
| Raymond R. Quirk | ||
| /s/ John D. Rood | Director | February 29, 2024 |
| John D. Rood | ||
Schedule I
SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES
| (In millions) | Amortized Cost | Fair Value | Amount Shown on Consolidated Balance Sheet |
|---|---|---|---|
| Fixed maturity securities, available for sale: | |||
| United States Government full faith and credit | $258 | $261 | $261 |
| United States Government sponsored entities | 34 | 31 | 31 |
| United States municipalities, states and territories | 1,776 | 1,567 | 1,567 |
| Foreign Governments | 263 | 226 | 226 |
| Corporate securities: | |||
| Finance, insurance and real estate | 7,526 | 6,895 | 6,895 |
| Manufacturing, construction and mining | 1,077 | 947 | 947 |
| Utilities, energy and related sectors | 2,825 | 2,374 | 2,374 |
| Wholesale/retail trade | 2,799 | 2,433 | 2,433 |
| Services, media and other | 4,553 | 3,930 | 3,930 |
| Hybrid securities | 668 | 618 | 618 |
| Non-agency residential mortgage-backed securities | 2,467 | 2,393 | 2,393 |
| Commercial mortgage-backed securities | 4,732 | 4,410 | 4,410 |
| Asset-backed securities | 9,273 | 8,929 | 8,929 |
| CLO securities | 5,350 | 5,405 | 5,405 |
| Total fixed maturity securities, available for sale | $43,601 | $40,419 | $40,419 |
| Equity securities | 682 | 606 | 606 |
| Limited partnerships: | |||
| Private equity | 1,277 | 1,277 | 1,277 |
| Real assets | 465 | 463 | 463 |
| Credit | 1,039 | 1,039 | 1,039 |
| Limited partnerships | 2,781 | 2,779 | 2,779 |
| Commercial mortgage loans | 2,538 | 2,253 | 2,538 |
| Residential mortgage loans | 2,798 | 2,545 | 2,798 |
| Other (primarily derivatives and company owned life insurance) | 1,621 | 1,697 | 1,697 |
| Short term investments | 1,452 | 1,452 | 1,452 |
| Total investments | $55,473 | $51,751 | $52,289 |
See Report of Independent Registered Public Accounting Firm
Schedule II
SUPPLEMENTAL CONDENSED BALANCE SHEET
| (In millions) | December 31, 2023 | December 31, 2022 |
|---|---|---|
| Assets | ||
| Investments in consolidated subsidiaries | $4,236 | $2,806 |
| Fixed maturity securities, available for sale | 54 | 54 |
| Cash and cash equivalents | 12 | 52 |
| Prepaid expenses and other assets | 3 | 6 |
| Income taxes receivable | 13 | 60 |
| Total assets | $4,318 | $2,978 |
| Liabilities and Equity | ||
| Accounts payable and other liabilities | 20 | 24 |
| Intercompany payables | 1 | 3 |
| Notes payable | 1,194 | 546 |
| Total liabilities | $1,215 | $573 |
| Equity: | ||
| F&G common stock, $0.001 par value; authorized 500,000,000 shares as of December 31, 2023 and 2022; outstanding of 126,332,142 and 126,409,904 as of December 31, 2023 and 2022, respectively, and issued of 127,234,902 and 126,409,904 as of December 31, 2023 and 2022, respectively | — | — |
| Additional paid-in-capital | 3,185 | 3,162 |
| Retained earnings | 1,926 | 2,061 |
| Accumulated other comprehensive earnings (loss) | (1,990) | (2,818) |
| Treasury stock, at cost (902,760 shares and 7,762 shares as of December 31, 2023 and2022, respectively) | (18) | — |
| Total equity | 3,103 | 2,405 |
| Total liabilities and equity | $4,318 | $2,978 |
Schedule II (continued)
SUPPLEMENTAL CONDENSED INCOME STATEMENT
| (In millions) | Year ended December 31, | ||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Revenues: | |||
| Life insurance premiums and other fees | $3 | $— | $— |
| Interest and investment income | 16 | 3 | — |
| Total revenues | 19 | 3 | — |
| Expenses: | |||
| Other operating expenses | 5 | — | — |
| Interest expense | 75 | 7 | 3 |
| Total expenses | 80 | 7 | 3 |
| Earnings (loss) before income tax expense and equity in earnings of subsidiaries | (61) | (4) | (3) |
| Income tax expense (benefit) | (13) | (24) | — |
| Earnings (loss) before equity in earnings of subsidiaries | (48) | 20 | (3) |
| Equity in earnings (loss) of subsidiaries | (10) | 615 | 1,243 |
| Net earnings (loss) | $(58) | $635 | $1,240 |
Schedule II (continued)
SUPPLEMENTAL CONDENSED CASH FLOW STATEMENT
| (In millions) | Year ended December 31, | ||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Cash flows from operating activities: | |||
| Net earnings (loss) | $(58) | $635 | $1,240 |
| Adjustments to reconcile net earnings to net cash (used in) provided by operating activities: | |||
| Gain on sales of investments | — | 1 | — |
| Equity in earnings (loss) of subsidiaries | 10 | (615) | (1,243) |
| Net change in income taxes | 47 | (25) | — |
| Stock-based compensation | 23 | 12 | 9 |
| Net (increase) decrease in other assets and other liabilities | (28) | (9) | (3) |
| Net cash provided by (used in) operating activities | (6) | (1) | 3 |
| Cash flows from investing activities: | |||
| Proceeds from sales, calls and maturities of investment securities | 2 | 4 | — |
| Net cash provided by (used in) investing activities | 2 | 4 | — |
| Cash flows from financing activities: | |||
| Borrowings | 845 | 550 | — |
| Debt issuance costs | (12) | (4) | — |
| Capital contributions | (589) | (500) | — |
| Purchases of treasury stock | (18) | — | — |
| Dividends paid | (77) | — | — |
| Net revolving credit facility repayments | (185) | — | — |
| Net cash provided by (used in) financing activities | (36) | 46 | — |
| Net change in cash and cash equivalents | (40) | 49 | 3 |
| Cash and cash equivalents at beginning of year | 52 | 3 | — |
| Cash and cash equivalents at end of year | $12 | $52 | $3 |
Schedule III
SUPPLEMENTARY INSURANCE INFORMATION
| (In millions) | Year ended December 31, | ||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Deferred acquisition costs | $2,215 | $1,411 | $784 |
| Future policy benefits, losses, claims and loss expenses | 7,050 | 5,021 | 4,918 |
| Other policy claims and benefits payable | 92 | 109 | 109 |
| Life insurance premiums and other fees | 2,413 | 1,704 | 1,407 |
| Interest and investment income | 2,211 | 1,655 | 1,852 |
| Benefits, claims, losses and settlement expenses | (3,553) | (1,126) | (1,932) |
| Amortization of deferred policy acquisition costs | (191) | (99) | (46) |
| Other operating expenses, net of deferrals | (146) | (102) | (105) |
Schedule IV
SUPPLEMENTAL REINSURANCE SCHEDULE
| For the year ended December 31, 2023 | Gross Amount | Ceded to other companies | Assumed from other companies | Net Amount | Percentage of amount assumed to net |
|---|---|---|---|---|---|
| Life insurance in force | $8,448 | $(1,436) | $— | $7,012 | —% |
| Premiums and other considerations: | |||||
| Traditional life insurance premiums | 148 | (105) | — | 43 | —% |
| Life-contingent PRT premiums | 1,964 | — | — | 1,964 | —% |
| Annuity product charges and other fees | 455 | (49) | — | 406 | —% |
| Total premiums and other considerations | $2,567 | $(154) | $— | $2,413 | —% |
| For the year ended December 31, 2022 | Gross Amount | Ceded to other companies | Assumed from other companies | Net Amount | Percentage of amount assumed to net |
|---|---|---|---|---|---|
| Life insurance in force | $6,296 | $(1,524) | $— | $4,772 | —% |
| Premiums and other considerations: | |||||
| Traditional life insurance premiums | 160 | (128) | — | 32 | —% |
| Life-contingent PRT premiums | 1,362 | — | — | 1,362 | —% |
| Annuity product charges and other fees | 360 | (50) | — | 310 | —% |
| Total premiums and other considerations | $1,882 | $(178) | $— | $1,704 | —% |
| For the year ended December 31, 2021 | Gross Amount | Ceded to other companies | Assumed from other companies | Net Amount | Percentage of amount assumed to net |
|---|---|---|---|---|---|
| Life insurance in force | $4,895 | $(1,642) | $— | $3,253 | —% |
| Premiums and other considerations: | |||||
| Traditional life insurance premiums | 168 | (137) | — | 31 | —% |
| Life-contingent PRT premiums | 1,146 | — | — | 1,146 | —% |
| Annuity product charges and other fees | 281 | (51) | — | 230 | —% |
| Total premiums and other considerations | $1,595 | $(188) | $— | $1,407 | —% |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.